Medtronic plc (MDT) PEG Ratio: 6.73
Is Medtronic plc’s PEG ratio high or low?
Medtronic plc's PEG ratio of 6.73 is 147% above its 4-year average of 2.73, near the high end of its 4-year range (0.70–6.73).
79.95% above its 12-month average of 3.74.
MDT PEG Ratio Chart
MDT Average PEG Ratio Chart
MDT Current vs Average PEG Ratio Chart
MDT PEG Ratio Metrics
PEG RATIO
6.73
PEG RATIO AVG TTM
3.74
PEG RATIO AVG 3Y
3.74
PEG RATIO AVG 5Y
2.73
PEG RATIO AVG 10Y
4.11
PEG RATIO AVG 15Y
3.91
PEG RATIO AVG 20Y
3.12
CURRENT VS TTM AVG
+79.95%
CURRENT VS 3Y AVG
+79.95%
CURRENT VS 5Y AVG
+146.82%
CURRENT VS 10Y AVG
+63.63%
CURRENT VS 15Y AVG
+72.22%
CURRENT VS 20Y AVG
+115.76%
MDT Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | $103.17B | 6.73 | 3.74 | 3.74 | 2.73 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $112.95B | 3.23 | 2.58 | 1.90 | 1.47 |
| Bristol-Myers Squibb Company (BMY) | $116.19B | 1.70 | 0.24 | 0.24 | 0.18 |
| Elevance Health Inc. (ELV) | $86.69B | 2.55 | 6.99 | 4.82 | 3.75 |
| Cigna Corporation (CI) | $78.38B | 0.15 | 0.15 | 0.29 | 0.24 |
| Danaher Corporation (DHR) | $128.27B | 87.42 | 1.21 | 1.11 | 1.91 |
| CVS Health Corporation (CVS) | $129.25B | N/A | 0.13 | 1.20 | 1.16 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.00B | 3.38 | 2.53 | 2.53 | 1.33 |
| Intuitive Surgical, Inc. (ISRG) | $146.23B | 3.17 | 3.02 | 2.60 | 2.27 |
| Pfizer Inc. (PFE) | $149.18B | N/A | 0.07 | 0.13 | 0.16 |
Growth-Adjusted Valuation
PEG Ratio
6.73
P/E Ratio
21.5
Medtronic plc PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc PEG Ratio FAQ
- What is the PEG ratio for Medtronic plc (MDT)?
- The PEG ratio for MDT stock is 6.73.
- Is Medtronic plc's PEG ratio high or low?
- Medtronic plc's PEG ratio of 6.73 is 147% above its 4-year average of 2.73, near the high end of its 4-year range (0.70–6.73).
- What is the TTM average PEG ratio for Medtronic plc (MDT)?
- The TTM average PEG ratio for MDT stock is 3.74.
- What is the 3Y average PEG ratio for Medtronic plc (MDT)?
- The 3Y average PEG ratio for MDT stock is 3.74.
- What is the 5Y average PEG ratio for Medtronic plc (MDT)?
- The 5Y average PEG ratio for MDT stock is 2.73.
- What is the 10Y average PEG ratio for Medtronic plc (MDT)?
- The 10Y average PEG ratio for MDT stock is 4.11.
- What is the 15Y average PEG ratio for Medtronic plc (MDT)?
- The 15Y average PEG ratio for MDT stock is 3.91.
- What is the 20Y average PEG ratio for Medtronic plc (MDT)?
- The 20Y average PEG ratio for MDT stock is 3.12.
Medtronic plc PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2026-04-24 | 6.73 |
| 2025-04-25 | 0.75 |
| 2022-04-29 | 0.70 |
| 2020-04-24 | 7.36 |
| 2019-04-30 | 0.51 |
| 2017-04-30 | 1.75 |
| 2016-04-30 | 10.99 |
| 2012-04-30 | 0.57 |
| 2011-04-30 | 5.81 |
| 2010-04-30 | 0.30 |
| 2007-04-30 | 1.39 |
| 2006-04-30 | 0.57 |
| 2004-04-30 | 1.36 |
| 2003-04-30 | 0.59 |
| 2000-04-30 | 0.45 |
| 1998-04-30 | 26.14 |
| 1997-04-30 | 2.55 |
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha